HIV and Malignancies

The purpose of this funding is to stimulate research on HIV-associated malignancies and to foster multidisciplinary collaborations between NCI-designated Cancer Centers and CFAR investigators by supporting one-year pilot research projects in HIV-associated malignancies. Pilot studies may include basic, translational, and clinical research on the etiology, pathogenesis, prevention, and management of AIDS-defining and non-AIDS-defining malignancies.

  • Term: 1 year (when available)
  • Number of awards: Dependent on available funding
  • Award amount: $75,000-100,000+ in total costs

9 Awards

Award Recipient Award date Award Type
Testing the Performance and Local Laboratory Capacity for p16 <sup>INK4a</sup> ELISA for Cervical Cancer Screening Among HIV-Infected Women in Western Kenya Megan Huchko Fall HIV and Malignancies
New Approaches in the Diagnosis and Treatment of AIDS-Related Primary CNS Lymphoma James Rubenstein Fall HIV and Malignancies
Building a Population-Based Cancer Registry in Dar es Salaam, Tanzania: A Pilot Project to Evaluate Completeness and Validity of Pathologic Data Katherine Van Loon Fall HIV and Malignancies
Biomarkers that Predict the Response of AIDS-Related Kaposi's Sarcoma to Antiretroviral Therapy and the Risk of Developing Immune Reconstitution Inflammatory Syndrome Stefanie Sowinski Fall HIV and Malignancies
Determining the Feasibility and Accuracy of a Novel Biomarker for Cervical Dysplasia Among HIV-Infected Women in Western Kenya Megan Huchko Fall HIV and Malignancies
New Approaches in the Diagnosis and Treatment of AIDS-Related Primary CNS Lymphoma James Rubenstein Fall HIV and Malignancies
Determinants of Late-Stage Diagnosis of HIV-Associated Kaposi Sarcoma in Africa Erin Amerson Fall HIV and Malignancies
Colorectal Neoplasia and Cancer among Patients with HIV Infection Ma Somsouk Fall HIV and Malignancies
Pathology of Kaposi's Sarcoma-Related Immune Reconstitution Inflammatory Syndrome Jeffrey Martin Spring HIV and Malignancies

Contacts

Subscribe to HIV and Malignancies